Bausch Health Companies (BHC) Change in Receivables (2009 - 2026)
Bausch Health Companies (BHC) posted Change in Receivables of $70.0 million for Q2 2026, up 147.3% sequentially from -$148.0 million in Q1 2026, and down 23.08% YoY from $91.0 million in Q2 2025.
Bausch Health Companies (BHC) Change in Receivables (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Change in Receivables for 18 years, with the latest figure at $70.0 million in Q2 2026.
- Quarterly Change in Receivables fell 23.08% year-over-year to $70.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $75.0 million (up 20.97% YoY) and the FY2025 annual result came in at $134.0 million, down 37.96% from the prior year.
- Change in Receivables grew to $70.0 million in Q2 2026 per BHC's latest filing, from -$148.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $231.0 million in Q3 2023 and troughed at -$197.0 million in Q1 2022.
- A 5-year average of $29.1 million and a median of $58.0 million in 2023 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 1047.83% in 2025, down 274.6% in 2025.
- Over 5 years, Change in Receivables stood at $31.0 million in 2022, then plunged by 38.71% to $19.0 million in 2023, then soared by 447.37% to $104.0 million in 2024, then slumped by 162.5% to -$65.0 million in 2025, then jumped by 207.69% to $70.0 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $70.0 million, -$148.0 million, and -$65.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | 70.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.00 Mn |
| Jun 30, 2026 | 70.00 Mn |
| Mar 31, 2026 | -148.00 Mn |
| Mar 31, 2026 | -148.00 Mn |
| Dec 31, 2025 | -65.00 Mn |
| Dec 31, 2025 | -65.00 Mn |
| Sep 30, 2025 | 218.00 Mn |
| Sep 30, 2025 | 218.00 Mn |
| Jun 30, 2025 | 91.00 Mn |
| Jun 30, 2025 | 91.00 Mn |
| Mar 31, 2025 | -110.00 Mn |
| Mar 31, 2025 | -110.00 Mn |
| Dec 31, 2024 | 104.00 Mn |
| Dec 31, 2024 | 104.00 Mn |
| Sep 30, 2024 | -23.00 Mn |
| Sep 30, 2024 | -23.00 Mn |
| Jun 30, 2024 | 72.00 Mn |
| Jun 30, 2024 | 72.00 Mn |
| Mar 31, 2024 | 63.00 Mn |
| Mar 31, 2024 | 63.00 Mn |